Page 9 of 13
Synthetic SARS-CoV-2 Spike-Based DNA Vaccine Elicits Robust and Long-Lasting Th1 Humoral and Cellular Immunity in Mice
2021 Alamri, SS
Tags: COVID-19, DNA, Improved Performance, Mouse, Respiratory Viruses, Tropis
September 7, 2021
In the pipeline: What the next wave of COVID-19 vaccines could look like
We take a look at some of the COVID-19 vaccine candidates moving through clinical trials.

Tags: COVID-19, Stratis, Tropis, Tropis/Stratis
September 1, 2021
Indian Government Authorizes Needle-Free Covid Vaccine
On Friday, the Indian government authorized a needle-free Covid-19 vaccine developed by an indigenous pharmaceutical company.

Tags: COVID-19, Stratis, Tropis, Tropis/Stratis
August 26, 2021
PharmaJet partner Zydus Cadila announces Emergency Use Authorization approval for world’s first plasmid DNA COVID-19 vaccine
GOLDEN, Colo. — August 23, 2021 – PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner, Zydus Cadila has received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the world’s first Plasmid DNA Vaccine for COVID-19. The vaccine, ZyCoV-D, is exclusively administered using the PharmaJet Tropis® Needle-free Injection System.
Tags: COVID-19, DNA, Nucleic Acid, Tropis
August 23, 2021
Cellular and Humoral Immunogenicity of a Candidate DNA Vaccine Expressing SARS-CoV-2 Spike Subunit 1
2021 Alluhaybi, KA
Tags: COVID-19, DNA, Mouse, Respiratory Viruses, Tropis
August 4, 2021
Safety and Immunogenicity of a DNA SARS-CoV-2 vaccine (ZyCoV-D): Results of an open-label, non-randomized phase I part of phase I/II clinical study by intradermal route in healthy subjects in India
2021 Momin, T
Tags: DNA, Improved Performance, Phase 1/2, Respiratory Viruses, Tropis
August 1, 2021
Covid-19:Decision On Zydus Cadila Zyov-D Approval Expected Soon, Says Dr VK Paul
New Delhi: A decision on the approval of Zydus Cadila’s COVID-19 vaccine Zydus Cov-D is expected soon…

July 13, 2021
Zydus Cadila plans to roll out COVID vaccine 45-60 days after EUA nod; key points on needle-free, plasmid DNA shot
ZyCov-D when approved will help not only adults but also adolescents in the 12 to 18 years age group

Tags: COVID-19, Stratis, Tropis, Tropis/Stratis
Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models
2021 Dey, A
Tags: COVID-19, DNA, Rabbit, Respiratory Viruses, Stratis
July 5, 2021
PharmaJet partner Zydus Cadila seeks EUA on world’s first plasmid DNA COVID-19 vaccine
GOLDEN, Colo. — July 7, 2021 – PharmaJet®, the maker of innovative, needle-free injection technology, today announced that its partner Zydus Cadila has applied for Emergency Use Authorization (EUA) to the office of the Drug Controller General of India (DCGI) for its plasmid DNA Vaccine against COVID-19. The vaccine, ZyCoV-D, will be exclusively administered using the PharmaJet Tropis® Needle-free Injection System. Zydus Cadila is a global pharmaceutical company based in India, that develops, manufactures, and markets a broad range of healthcare therapies, including small molecule drugs, biologic therapeutics, and vaccines.
Tags: COVID-19, DNA, Nucleic Acid, Tropis
July 2, 2021
COVID-19 DNA vaccine trial commences Down Under
Researchers are set to commence the first Phase 1 human trial …

Tags: COVID-19, Stratis, Tropis, Tropis/Stratis
July 1, 2021
Astonishing New Trials For A Needle-Free Covid Vaccine
The trial of a needle-free covid vaccine is now being tested on volunteers throughout Australia.

Tags: COVID-19, Stratis, Tropis, Tropis/Stratis
Update: PharmaJet Needle-free COVID-19 Vaccine Trial
GOLDEN, Colo. — June 30, 2021 — PharmaJet®, the maker of innovative, needle-free injection technology, today announced that patient enrollment has started for the phase 1 trial in Australia using its Needle-free Injection Systems to deliver a vaccine against SARS-CoV-2. COVIGEN, a DNA-based vaccine was developed by French-Thai pharmaceutical company BioNet-Asia in collaboration with and Melbourne-based biotech Technovalia. The PharmaJet System was chosen due to its record of increasing the effectiveness of DNA vaccines, ease-of-use, and speed of the delivery system compared to traditional needle and syringe.
Tags: COVID-19, DNA, Nucleic Acid, Stratis, Tropis, Tropis/Stratis
June 28, 2021
The Lancet Publication Confirms Viability of Intradermal Polio Vaccination
GOLDEN, Colo. — June 3, 2021– A systematic review and meta-analysis published in the April 30, 2021 issue of The Lancet strengthens evidence from previous publications that fractional dose delivery is a viable alternative to full dose inactivated polio vaccine (IPV). Previous studies have shown that two doses of intradermally-delivered IPV (60% less vaccine) were more immunogenic than one full dose delivered intramuscularly. Intradermal fractional dose delivery also lowers the total cost of vaccination substantially.
May 31, 2021
Insulin-like growth factor I reduces atherosclerosis in Rapacz pigs
2021 Sukhanov
Tags: Atherosclerosis, DNA, Other Applications, Pig, Stratis
May 14, 2021
Global NGO expands use of PharmaJet for Polio Eradication Campaigns
GOLDEN, Colo. — March 9, 2021 — PharmaJet ® , the maker of innovative, needle-free injection technology, today announced that a global NGO (Non-governmental organization) has expanded the use of its Tropis® Needle-free Injection System in polio eradication campaigns. The latest country addition, Somalia, adds to the already successful vaccination programs in Pakistan, Cuba, The Gambia and others.
March 5, 2021
Effective and Safe Stimulation of Humoral and Cell-Mediated Immunity by Intradermal Immunization with a Cyclic Dinucleotide/Nanoparticle Combination Adjuvant
2021 Hernandez-Franco, JF
Tags: Adjuvants, Nanoparticle, Other Applications, Pig, Tropis
February 15, 2021
Small animal jet injection technique results in enhanced immunogenicity of hantavirus DNA vaccines
2021 Brocato, RL
Tags: ANDV, DNA, DOBV, Hamster, Hantaviruses, HTNV, Improved Performance, PUUV, SEOV, SNV, Tropis
February 12, 2021
Assessment of immunogenicity and protective efficacy of ZyCoV-D DNA vaccine candidates in Rhesus macaques against SARS-CoV-2 infection
2021 Yadav, P
Tags: COVID-19, DNA, Improved Performance, Non-Human Primate, Respiratory Viruses, Tropis
February 2, 2021
Protective efficacy of a SARS-CoV-2 DNA vaccine in wild-type and immunosuppressed Syrian hamsters
2021 Brocato, RL
Tags: COVID-19, DNA, Hamster, Improved Performance, Respiratory Viruses, Tropis
January 25, 2021
Page 9 of 13

